Published in Vaccine on March 07, 2003
The chlamydial plasmid-encoded protein pgp3 is secreted into the cytosol of Chlamydia-infected cells. Infect Immun (2008) 1.97
Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence-associated genes. Infect Immun (2013) 1.82
Toll-like receptor 2 activation by Chlamydia trachomatis is plasmid dependent, and plasmid-responsive chromosomal loci are coordinately regulated in response to glucose limitation by C. trachomatis but not by C. muridarum. Infect Immun (2011) 1.56
Characterization of Pgp3, a Chlamydia trachomatis plasmid-encoded immunodominant antigen. J Bacteriol (2010) 1.18
Antibodies from women urogenitally infected with C. trachomatis predominantly recognized the plasmid protein pgp3 in a conformation-dependent manner. BMC Microbiol (2008) 1.10
Unraveling the basic biology and clinical significance of the chlamydial plasmid. J Exp Med (2011) 0.99
Live-attenuated influenza viruses as delivery vectors for Chlamydia vaccines. Immunology (2007) 0.95
Identification of immunodominant antigens by probing a whole Chlamydia trachomatis open reading frame proteome microarray using sera from immunized mice. Infect Immun (2010) 0.90
Activity of cathelicidin peptides against Chlamydia spp. Antimicrob Agents Chemother (2005) 0.89
Chlamydia trachomatis vaccine research through the years. Infect Dis Obstet Gynecol (2011) 0.86
Proteomic identification of immunodominant chlamydial antigens in a mouse model. J Proteomics (2012) 0.84
Structure of the Chlamydia trachomatis immunodominant antigen Pgp3. J Biol Chem (2013) 0.84
Induction of protective immunity against Chlamydia muridarum intravaginal infection with the chlamydial immunodominant antigen macrophage infectivity potentiator. Microbes Infect (2013) 0.82
Infection of human monocytes by Chlamydia pneumoniae and Chlamydia trachomatis: an in vitro comparative study. BMC Res Notes (2014) 0.81
Chlamydial Plasmid-Encoded Virulence Factor Pgp3 Neutralizes the Antichlamydial Activity of Human Cathelicidin LL-37. Infect Immun (2015) 0.80
Dendritic cells and vaccine design for sexually-transmitted diseases. Microb Pathog (2012) 0.80
Chlamydial Plasmid-Dependent Pathogenicity. Trends Microbiol (2016) 0.77
A vaccine formulated with the major outer membrane protein can protect C3H/HeN, a highly susceptible strain of mice, from a Chlamydia muridarum genital challenge. Immunology (2015) 0.76
Activity of Cathelicidin Peptides against Simkania negevensis. Int J Pept (2011) 0.75
Update on Chlamydia trachomatis Vaccinology. Clin Vaccine Immunol (2017) 0.75
A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci U S A (2006) 4.45
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med (2003) 3.83
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis (2013) 2.95
Rational design of a meningococcal antigen inducing broad protective immunity. Sci Transl Med (2011) 2.59
Borrelia burgdorferi NapA-driven Th17 cell inflammation in lyme arthritis. Arthritis Rheum (2008) 2.45
Qualitative and quantitative assessment of meningococcal antigens to evaluate the potential strain coverage of protein-based vaccines. Proc Natl Acad Sci U S A (2010) 2.30
Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccine. J Immunol (2004) 2.13
Genomic approach for analysis of surface proteins in Chlamydia pneumoniae. Infect Immun (2002) 1.94
Chikungunya virus in North-Eastern Italy: a seroprevalence survey. Am J Trop Med Hyg (2010) 1.94
Neisseria meningitidis is structured in clades associated with restriction modification systems that modulate homologous recombination. Proc Natl Acad Sci U S A (2011) 1.84
Previously unrecognized vaccine candidates against group B meningococcus identified by DNA microarrays. Nat Biotechnol (2002) 1.83
The region comprising amino acids 100 to 255 of Neisseria meningitidis lipoprotein GNA 1870 elicits bactericidal antibodies. Infect Immun (2005) 1.68
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein. Infect Immun (2008) 1.61
Distribution and genetic variability of three vaccine components in a panel of strains representative of the diversity of serogroup B meningococcus. Vaccine (2009) 1.58
Single-reaction, multiplex, real-time rt-PCR for the detection, quantitation, and serotyping of dengue viruses. PLoS Negl Trop Dis (2013) 1.57
Isolation of usutu virus in Germany. Am J Trop Med Hyg (2011) 1.55
The Chikungunya epidemic in Italy and its repercussion on the blood system. Blood Transfus (2008) 1.53
Diagnosis of bloodstream infections in immunocompromised patients by real-time PCR. J Infect (2009) 1.50
Laboratory diagnosis of syphilis with automated immunoassays. J Clin Lab Anal (2009) 1.50
Prevalence and genetic diversity of candidate vaccine antigens among invasive Neisseria meningitidis isolates in the United States. Vaccine (2011) 1.40
Characterization of fHbp, nhba (gna2132), nadA, porA, and sequence type in group B meningococcal case isolates collected in England and Wales during January 2008 and potential coverage of an investigational group B meningococcal vaccine. Clin Vaccine Immunol (2010) 1.36
Chikungunya: an emerging and spreading arthropod-borne viral disease. J Infect Dev Ctries (2009) 1.33
Characterization of fHbp, nhba (gna2132), nadA, porA, sequence type (ST), and genomic presence of IS1301 in group B meningococcal ST269 clonal complex isolates from England and Wales. J Clin Microbiol (2009) 1.32
West Nile virus in Italy: a further threat to blood safety, a further challenge to the blood system. Blood Transfus (2008) 1.29
Approach to discover T- and B-cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. Proc Natl Acad Sci U S A (2011) 1.27
Putative vaccine antigens from Neisseria meningitidis recognized by serum antibodies of young children convalescing after meningococcal disease. J Infect Dis (2004) 1.27
Evaluation of LIAISON Treponema Screen, a novel recombinant antigen-based chemiluminescence immunoassay for laboratory diagnosis of syphilis. Clin Diagn Lab Immunol (2005) 1.26
Characterization of diverse subvariants of the meningococcal factor H (fH) binding protein for their ability to bind fH, to mediate serum resistance, and to induce bactericidal antibodies. Infect Immun (2010) 1.24
Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine (2005) 1.19
Epitope mapping of a bactericidal monoclonal antibody against the factor H binding protein of Neisseria meningitidis. J Mol Biol (2008) 1.17
Conventional and molecular techniques for the early diagnosis of bacteraemia. Int J Antimicrob Agents (2010) 1.16
Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine (2012) 1.15
Inflammatory cytokine expression is associated with chikungunya virus resolution and symptom severity. PLoS Negl Trop Dis (2011) 1.12
Molecular detection of Treponema denticola and Porphyromonas gingivalis in carotid and aortic atheromatous plaques by FISH: report of two cases. J Med Microbiol (2005) 1.11
Mosquito, bird and human surveillance of West Nile and Usutu viruses in Emilia-Romagna Region (Italy) in 2010. PLoS One (2012) 1.08
Prevalence and sequence variations of the genes encoding the five antigens included in the novel 5CVMB vaccine covering group B meningococcal disease. Vaccine (2009) 1.05
Antitumor activity of sustained N-myc reduction in rhabdomyosarcomas and transcriptional block by antigene therapy. Clin Cancer Res (2011) 1.05
Immunological evaluation and cellular location analysis of the TprI antigen of Treponema pallidum subsp. pallidum. Infect Immun (2005) 1.05
Comparative evaluation of three different ELISA methods for the diagnosis of early culture-confirmed Lyme disease in Italy. J Med Microbiol (2005) 1.04
Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings. Vaccine (2005) 1.02
Laboratory diagnosis of late-onset sepsis in newborns by multiplex real-time PCR. J Med Microbiol (2009) 1.02
Detection of Usutu virus within a West Nile virus surveillance program in Northern Italy. Vector Borne Zoonotic Dis (2010) 1.01
Phylogenetic analysis of West Nile virus isolates, Italy, 2008-2009. Emerg Infect Dis (2011) 1.00
False-positive transcription-mediated amplification assay detection of West Nile virus in blood from a patient with viremia caused by an Usutu virus infection. J Clin Microbiol (2010) 1.00
HadA is an atypical new multifunctional trimeric coiled-coil adhesin of Haemophilus influenzae biogroup aegyptius, which promotes entry into host cells. Cell Microbiol (2009) 1.00
Plasma levels of bacterial DNA in HIV infection: the limits of quantitative polymerase chain reaction. J Infect Dis (2010) 0.99
Blood culture systems: rapid detection--how and why? Int J Antimicrob Agents (2009) 0.98
Detection of Usutu-virus-specific IgG in blood donors from northern Italy. Vector Borne Zoonotic Dis (2012) 0.98
Pneumococcal carriage in young children one year after introduction of the 13-valent conjugate vaccine in Italy. PLoS One (2013) 0.97
NarE: a novel ADP-ribosyltransferase from Neisseria meningitidis. Mol Microbiol (2003) 0.97
Humans parasitized by the hard tick Ixodes ricinus are seropositive to Midichloria mitochondrii: is Midichloria a novel pathogen, or just a marker of tick bite? Pathog Glob Health (2012) 0.96
Presence of the A226V mutation in autochthonous and imported Italian chikungunya virus strains. Clin Infect Dis (2008) 0.96
An analysis of the sequence variability of meningococcal fHbp, NadA and NHBA over a 50-year period in the Netherlands. PLoS One (2013) 0.96
Influence of sequence variability on bactericidal activity sera induced by Factor H binding protein variant 1.1. Vaccine (2010) 0.95
Evaluation of the BioPlex 2200 syphilis system as a first-line method of reverse-sequence screening for syphilis diagnosis. Clin Vaccine Immunol (2013) 0.95
CT043, a protective antigen that induces a CD4+ Th1 response during Chlamydia trachomatis infection in mice and humans. Infect Immun (2009) 0.95
A neutralizing monoclonal antibody targeting the acid-sensitive region in chikungunya virus E2 protects from disease. PLoS Negl Trop Dis (2013) 0.94
Fine analysis of genetic diversity of the tpr gene family among treponemal species, subspecies and strains. PLoS Negl Trop Dis (2013) 0.93
Comparative evaluation of two enzyme linked immunosorbent assay methods and three Western Blot methods for the diagnosis of culture-confirmed early Lyme borreliosis in Italy. New Microbiol (2005) 0.93
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles (2013) 0.93
Diversity of Greek meningococcal serogroup B isolates and estimated coverage of the 4CMenB meningococcal vaccine. BMC Microbiol (2014) 0.93
The 2007 epidemic outbreak of Chikungunya virus infection in the Romagna region of Italy: a new perspective for the possible diffusion of tropical diseases in temperate areas? New Microbiol (2008) 0.92
Proteome analysis of Neisseria meningitidis serogroup A. Proteomics (2004) 0.92
Routine use of a real-time polymerase chain reaction method for detection of bloodstream infections in neutropaenic patients. Diagn Microbiol Infect Dis (2012) 0.91
Innate host responses to West Nile virus: Implications for central nervous system immunopathology. World J Virol (2013) 0.91
Multiple nucleotide substitutions in the Neisseria meningitidis serogroup C ctrA gene cause false-negative detection by real-time PCR. J Clin Microbiol (2010) 0.90
Activity of cathelicidin peptides against Chlamydia spp. Antimicrob Agents Chemother (2005) 0.89
Microbiological and pharmacological tests on new antibiotic-loaded PMMA-based composites for the treatment of osteomyelitis. J Orthop Res (2011) 0.88
Recovery of Enterococcus faecalis in root canal lumen of patients with primary and secondary endodontic lesions. New Microbiol (2008) 0.88
Comparative in vitro activity of five cathelicidin-derived synthetic peptides against Leptospira, Borrelia and Treponema pallidum. J Antimicrob Chemother (2002) 0.88
Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant. Int Orthop (2013) 0.88
A rapid and specific real-time RT-PCR assay to identify Usutu virus in human plasma, serum, and cerebrospinal fluid. J Clin Virol (2010) 0.87
Comparative genomic and phylogenetic analysis of the first Usutu virus isolate from a human patient presenting with neurological symptoms. PLoS One (2013) 0.87
How can the microbiologist help in diagnosing neonatal sepsis? Int J Pediatr (2012) 0.87
Interlaboratory study to evaluate the performance of laboratories involved in West Nile virus RNA screening of blood and blood components by nucleic acid amplification testing in Italy. Blood Transfus (2011) 0.87
Seroepidemiologic survey for Chlamydia suis in wild boar (Sus scrofa) populations in Italy. J Wildl Dis (2011) 0.86
In silico identification of novel bacterial ADP-ribosyltransferases. Int J Med Microbiol (2004) 0.86
Neisseria meningitidis factor H-binding protein fHbp: a key virulence factor and vaccine antigen. Expert Rev Vaccines (2015) 0.86
Safety and efficacy of two types of influenza vaccination in heart transplant recipients: a prospective randomised controlled study. J Heart Lung Transplant (2005) 0.86
Draft Genome Sequences of Two Multidrug Resistant Klebsiella pneumoniae ST258 Isolates Resistant to Colistin. Genome Announc (2013) 0.86
Production of reactive oxygen species and expression of inducible nitric oxide synthase in rat isolated Kupffer cells stimulated by Leptospira interrogans and Borrelia burgdorferi. World J Gastroenterol (2006) 0.86
Sensitivity of Chlamydia suis to cathelicidin peptides. Vet Microbiol (2007) 0.85
Production of tumor necrosis factor alpha by Treponema pallidum, Borrelia burgdorferi s.l., and Leptospira interrogans in isolated rat Kupffer cells. FEMS Immunol Med Microbiol (2004) 0.84